Interactive effects of OPRM1 and DAT1 genetic variation on subjective responses to alcohol

Alcohol and Alcoholism

Volumn 49, Issue 3, 2014, Pages 261-270

  Ray, Lara A ^a   Bujarski, Spencer ^a   Squeglia, Lindsay M ^b   Ashenhurst, James R ^a   Anton, Raymond F ^c  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DOPAMINE TRANSPORTER; MU OPIATE RECEPTOR; PLACEBO; SODIUM CHLORIDE; ALCOHOL; OPRM1 PROTEIN, HUMAN; SLC6A3 PROTEIN, HUMAN;

ALCOHOL CONSUMPTION; ALCOHOL INDUCED STIMULATION; ALCOHOLISM; ALLELE; ARTICLE; CONTROLLED STUDY; GENETIC VARIABILITY; GENOTYPE; HETEROZYGOTE; HOMOZYGOTE; HUMAN; MAJOR CLINICAL STUDY; MOOD; PRIORITY JOURNAL; PROTEIN PROTEIN INTERACTION; SEDATION; SINGLE NUCLEOTIDE POLYMORPHISM; STIMULATION; ADULT; AFFECT; AGED; AROUSAL; DRUG EFFECTS; FEMALE; GENETICS; GENOTYPE ENVIRONMENT INTERACTION; INTRAVENOUS DRUG ADMINISTRATION; MALE; MIDDLE AGED; PHYSIOLOGY; RANDOMIZED CONTROLLED TRIAL; SINGLE BLIND PROCEDURE; VARIABLE NUMBER OF TANDEM REPEAT; YOUNG ADULT;

ADULT; AFFECT; AGED; ALCOHOLISM; AROUSAL; DOPAMINE PLASMA MEMBRANE TRANSPORT PROTEINS; ETHANOL; FEMALE; GENE-ENVIRONMENT INTERACTION; GENOTYPE; HUMANS; INFUSIONS, INTRAVENOUS; MALE; MIDDLE AGED; MINISATELLITE REPEATS; POLYMORPHISM, SINGLE NUCLEOTIDE; RECEPTORS, OPIOID, MU; SINGLE-BLIND METHOD; YOUNG ADULT;

EID: 84896899770     PISSN: 07350414     EISSN: 14643502     Source Type: Journal    
DOI: 10.1093/alcalc/agt183     Document Type: Article

References (46)

1. Aarts E, Roelofs A, Franke B et al.. (2010) Striatal dopamine mediates the interface between motivational and cognitive control in humans: evidence from genetic imaging. Neuropsychopharma cology 35:1943-51.
2. Anton RF, Oroszi G, O'Malley S et al.. (2008) An evaluation of mu-opioid receptor (OPRM1) as a predictor of naltrexone response in the treatment of alcohol dependence: results from the Combined Pharmacotherapies and Behavioral Interventions for Alcohol Dependence (COMBINE) study. Arch Gen Psychiatry 65:135-44.
3. Anton RF, Voronin KK, Randall PK, Myrick H, Tiffany A. (2012) Naltrexone modification of drinking effects in a subacute treatment and bar-lab paradigm: influence of OPRM1 and dopamine transporter (SLC6A3) genes. Alcohol Clin Exp Res 36:2000-7.
4. Barr CS, Schwandt M, Lindell SG et al.. (2007) Association of a functional polymorphism in the mu-opioid receptor gene with alcohol response and consumption in male rhesus macaques. Arch Gen Psychiatry 64:369-76.
5. Beck AT, Steer RA. (1993) Beck Anxiety Inventory Manual. San Antonio, TX.
6. Beck AT, Steer RA, Brown G. (1996) Manual for the Beck Depression Inventory-II. San Antonio, TX.
7. Bond C, LaForge KS, Tian M et al.. (1998) Single-nucleotide polymorphism in the human mu opioid receptor gene alters beta-endorphin binding and activity: possible implications for opiate addiction. Proc Natl Acad Sci USA 95:9608-13.
8. Dreher JC, Kohn P, Kolachana B, Weinberger DR, Berman KF. (2009) Variation in dopamine genes influences responsivity of the human reward system. Proc Natl Acad Sci USA 106:617-22.
9. Du Y, Nie Y, Li Y, Wan YJ. (2011) The association between the SLC6A3 VNTR 9-repeat allele and alcoholism-a meta-analysis. Alcohol Clin Exp Res 35:1625-34.
10. Ducci F, Goldman D. (2008) Genetic approaches to addiction: genes and alcohol. Addiction 103:1414-28.
11. Erblich J, Earleywine M. (1995) Distraction does not impair memory during intoxication: support for the attention-allocation model. J Stud Alcohol 56:444-8.
12. Filbey FM, Ray L, Smolen A, Claus ED, Audette A, Hutchison KE. (2008) Differential neural response to alcohol priming and alcohol taste cues is associated with DRD4 VNTR and OPRM1 genotypes. Alcohol Clin Exp Res 32:1113-23.
13. First MB, Spitzer RL, Gibbon M, Williams JBW. (1995) Structured Clinical Interview for DSM-IV Axis I disorders-Patient edition (SCID-I/P, version 2.0). New York: Biometrics Research Department, New York State Psychiatric Institute.
14. Flannery BA, Volpicelli JR, Pettinati HM. (1999) Psychometric properties of the Penn Alcohol Craving Scale. Alcohol Clin Exp Res 23:1289-95.
15. Forbes EE, Brown SM, Kimak M, Ferrell RE, Manuck SB, Hariri AR. (2009) Genetic variation in components of dopamine neurotransmission impacts ventral striatal reactivity associated with impulsivity. Mol Psychiatry 14:60-70.
16. Fuke S, Suo S, Takahashi N, Koike H, Sasagawa N, Ishiura S. (2001) The VNTR polymorphism of the human dopamine transporter (DAT1) gene affects gene expression. Pharmacogenomics J 1:152-6.
17. Gelernter J, Gueorguieva R, Kranzler HR et al.. (2007) Opioid receptor gene (OPRM1, OPRK1, and OPRD1) variants and response to naltrexone treatment for alcohol dependence: results from the VA Cooperative Study. Alcohol Clin Exp Res 31:555-63.
18. Gianoulakis C. (2009) Endogenous opioids and addiction to alcohol and other drugs of abuse. Curr Top Med Chem 9:999-1015.
19. Heilig M, Thorsell A, Sommer WH et al.. (2010) Translating the neuroscience of alcoholism into clinical treatments: from blocking the buzz to curing the blues. Neurosci Biobehav Rev 35:334-44.
20. Heilig M, Goldman D, Berrettini W, O'Brien CP. (2011) Pharmacogenetic approaches to the treatment of alcohol addiction. Nat Rev Neurosci 12:670-84.
21. Hines LM, Ray L, Hutchison K, Tabakoff B. (2005) Alcoholism: the dissection for endophenotypes. Dialogues Clin Neurosci 7:153-63.
22. Kendler KS, Prescott CA, Neale MC, Pedersen NL. (1997) Temperance board registration for alcohol abuse in a national sample of Swedish male twins, born 1902 to 1949. Arch Gen Psychiatry 54:178-84.
23. Koob GF, Kreek MJ. (2007) Stress, dysregulation of drug reward pathways, and the transition to drug dependence. Am J Psychiatry 164:1149-59.
24. Li TK, Yin SJ, Crabb DW, O'Connor S, Ramchandani VA. (2001) Genetic and environmental influences on alcohol metabolism in humans. Alcohol Clin Exp Res 25:136-44.
25. Martin CS, Earleywine M, Musty RE, Perrine MW, Swift RM. (1993) Development and validation of the Biphasic Alcohol Effects Scale. Alcohol Clin Exp Res 17:140-6.
26. McNair DM, Lorr M, Droppleman LF. (1971) Manual for the Profile of Mood States. San Diego: Educational & Industrial Testing Service.
27. Miller WR, Tonigan JS, Longabaugh R. (1995) The Drinker Inventory of Consequences (DrInC): An Instrument for Assessing Adverse Consequences of Alcohol Abuse. Rockville, MD: National Institute on Alcohol Abuse and Alcoholism.
28. O'Connor S, Morzorati S, Christian J, Li TK. (1998) Clamping breath alcohol concentration reduces experimental variance: application to the study of acute tolerance to alcohol and alcohol elimination rate. Alcohol Clin Exp Res 22:202-10.
29. Oslin DW, Berrettini W, Kranzler HR et al.. (2003) A functional polymorphism of the mu-opioid receptor gene is associated with naltrexone response in alcohol-dependent patients. Neuropsychopharmacology 28:1546-52.
30. Prescott CA, Kendler KS. (1999) Genetic and environmental contributions to alcohol abuse and dependence in a population-based sample of male twins. Am J Psychiatry 156:34-40.
31. Ramchandani VA, Bolane J, Li TK, O'Connor S. (1999) A physiologically-based pharmacokinetic (PBPK) model for alcohol facilitates rapid BrAC clamping. Alcohol Clin Exp Res 23:617-23.
32. Ramchandani VA, Umhau J, Pavon FJ et al.. (2011) A genetic determinant of the striatal dopamine response to alcohol in men. Mol Psychiatry 16:809-17.
33. Ray LA, Hutchison KE. (2004) A polymorphism of the mu-opioid receptor gene (OPRM1) and sensitivity to the effects of alcohol in humans. Alcohol Clin Exp Res 28:1789-95.
34. Ray LA, Hutchison KE. (2007) Effects of naltrexone on alcohol sensitivity and genetic moderators of medication response: a doubleblind placebo-controlled study. Arch Gen Psychiatry 64:1069-77.
35. Ray LA, Meskew-Stacer S, Hutchison KE. (2007) The relationship between prospective self-rating of alcohol sensitivity and craving and experimental results from two alcohol challenge studies. J Stud Alcohol Drugs 68:379-84.
36. Ray LA, Mackillop J, Monti PM. (2010a) Subjective responses to alcohol consumption as endophenotypes: advancing behavioral genetics in etiological and treatment models of alcoholism. Subst Use Misuse 45:1742-65.
37. Ray LA, Miranda R, Jr, Tidey JW et al.. (2010b) Polymorphisms of the mu-opioid receptor and dopamine D4 receptor genes and subjective responses to alcohol in the natural environment. J Abnorm Psychol 119:115-25.
38. Ray LA, Barr CS, Blendy JA, Oslin D, Goldman D, Anton RF. (2012) The role of the Asn40Asp polymorphism of the mu opioid receptor gene (OPRM1) on alcoholism etiology and treatment: a critical review. Alcohol Clin Exp Res 36:385-94.
39. Ray LA, Bujarski S, MacKillop J, Courtney KE, Monti PM, Miotto K. (2013) Subjective response to alcohol among alcoholdependent individuals: effects of the mu-opioid receptor (OPRM1) gene and alcoholism severity. Alcohol Clin Exp Res 37 (Suppl 1):E116-24.
40. Schacht JP, Anton RF, Voronin KE et al.. (2012) Interacting effects of naltrexone and OPRM1 and DAT1 variation on the neural response to alcohol cues. Neuropsychopharmacology 38:414-22.
41. Setiawan E, Pihl RO, Cox SM et al.. (2011) The effect of naltrexone on alcohol's stimulant properties and self-administration behavior in social drinkers: influence of gender and genotype. Alcohol Clin Exp Res 35:1134-41.
42. Singer JD. (1998) Using SAS PROC MIXED to fit multilevel models, hierarchical models, and individual growth models. J=Educ Behav Stat 24:323-55.
43. Skinner HA, Allen BA. (1982) Alcohol dependence syndrome: measurement and validation. J Abnorm Psychol 91:199-209.
44. Sobell LC, Sobell MB. (1980) Convergent validity: An approach to increasing confidence in treatment outcome conclusions with alcohol and drug abusers. In Sobell LC, Sobell MB, Ward E (eds). Evaluating Alcohol and Drug Abuse Treatment Effectiveness: Recent Advances. Elmsford, NY: Pergamon Press, 177-209.
45. Sullivan J, Sykora K, Schneiderman J, Naranjo C, Sellers E. (1989a) Assessment of alcohol withdrawal: the revised Clinical Institute Withdrawal Assessment for Alcohol scale (CIWA-AR). Br J Addict 84:1353-57.
46. Sullivan JT, Sykora K, Schneiderman J, Naranjo CA, Sellers EM. (1989b) Assessment of alcohol withdrawal: the revised clinical institute withdrawal assessment for alcohol scale (CIWA-Ar). Br J Addict 84:1353-7.